Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens

Journal of General Virology

Volumn 88, Issue 6, 2007, Pages 1708-1716

  Holst, Peter J ^a   Bartholdy, Christina ^a   Stryhn, Annette ^a   Thomsen, Allan R ^a   Christensen, Jan P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA 2 MICROGLOBULIN; EPITOPE; VIRUS GLYCOPROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOTHERAPY; INFECTION PREVENTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS MENINGITIS;

ADENOVIRIDAE; ANIMALS; ANTIGENS, VIRAL; BETA 2-MICROGLOBULIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPITOPES; FLOW CYTOMETRY; GENETIC VECTORS; LIVER; LUNG; LYMPHOCYTE SUBSETS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; SPLEEN; SURVIVAL ANALYSIS; VACCINES, SYNTHETIC; VIRAL VACCINES;

ADENOVIRIDAE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 34249775774     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82727-0     Document Type: Article

References (47)

1. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J. & Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687.
2. Bartholdy, C., Stryhn, A., Hansen, N. J., Buus, S. & Thomsen, A. R. (2003). Incomplete effector/memory differentiation of antigen-primed CD8+ T cells in gene gun DNA-vaccinated mice. Eur J Immunol 33, 1941-1948.
3. Bartholdy, C., Olszewska, W., Stryhn, A., Thomsen, A. R. & Openshaw, P. J. (2004a). Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis. J Gen Virol 85, 3017-3026.
4. Bartholdy, C., Stryhn, A., Christensen, J. P. & Thomsen, A. R. (2004b). Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection. J Immunol 173, 6284-6293.
5. Battegay, M., Cooper, S., Althage, A., Banziger, J., Hengartner, H. & Zinkernagel, R. M. (1991). Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods 33, 191-198.
6. Becker, T. C., Noel, R. J., Coats, W. S., Gomez-Foix, A. M., Alam, T., Gerard, R. D. & Newgard, C. B. (1994). Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43, 161-189.
7. Bowen, D. G. & Walker, C. M. (2005). Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946-952.
8. Boyer, J. L., Kobinger, G., Wilson, J. M. & Crystal, R. G. (2005). Adenovirus-based genetic vaccines for biodefense. Hum Gene Ther 16, 157-168.
9. Bruna-Romero, O., Gonzalez-Aseguinolaza, G., Hafalla, J. C., Tsuji, M. & Nussenzweig, R. S. (2001). Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc Natl Acad Sci U S A 98, 11491-11496.
10. Christensen, J. P., Marker, O. & Thomsen, A. R. (1994). The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand J Immunol 40, 373-382.
11. Cohen, J. (2005). Is an effective HIV vaccine feasible?. Science 309, 99.
12. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J. & other authors (2006), PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354.
13. Fitzgerald, J. C., Gao, G. P., Reyes-Sandoval, A., Pavlakis, G. N., Xiang, Z. Q., Wlazlo, A. P., Giles-Davis, W., Wilson, J. M. & Ertl, H. C. (2003). A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J Immunol 170, 1416-1422.
14. Fuller, M. J., Khanolkar, A., Tebo, A. E. & Zajac, A. J. (2004). Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J Immunol 172, 4204-4214.
15. Gandhi, R. T. & Walker, B. D. (2002). Immunologic control of HIV-1. Annu Rev Med 53, 149-172.
16. Gomez-Roman, V. R. & Robert-Guroff, M. (2003). Adenoviruses as vectors for HIV vaccines. AIDS Rev 5, 178-185.
17. Gourley, T. S., Wherry, E. J., Masopust, D. & Ahmed, R. (2004). Generation and maintenance of immunological memory. Semin Immunol 16, 323-333.
18. Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J. H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M. & Walker, C. M. (2003). HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659-662.
19. + T-cell responses induced by DNA immunization. J Virol 74, 8286-8291.
20. b molecules. Virology 234, 62-73.
21. Klavinskis, L. S., Whitton, J. L. & Oldstone, M. B. (1989). Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J Virol 63, 4311-4316.
22. Klavinskis, L. S., Whitton, J. L., Joly, E. & Oldstone, M. B. (1990). Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178, 393-400.
23. Kovacs, J. A. & Masur, H. (2000). Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 342, 1416-1429.
24. + T cells during viral infection: correlation with stable memory development. J Gen Virol 83, 2123-2133.
25. Kundig, T. M., Shahinian, A., Kawai, K., Mittrucker, H. W., Sebzda, E., Bachmann, M. F., Mak, T. W. & Ohashi, P. S. (1996). Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5, 41-52.
26. Lau, L. L., Jamieson, B. D., Somasundaram, T. & Ahmed, R. (1994). Cytotoxic T-cell memory without antigen. Nature 369, 648-652.
27. Liu, Z. X., Govindarajan, S., Okamoto, S. & Dennert, G. (2001). Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J Immunol 166, 3035-3041.
28. Oldstone, M. B., Tishon, A., Eddleston, M., de la Torre, J. C., McKee, T. & Whitton, J. L. (1993). Vaccination to prevent persistent viral infection. J Virol 67, 4372-4378.
29. + T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. J Immunol 171, 6774-6779.
30. Rodrigues, E. G., Zavala, F., Eichinger, D., Wilson, J. M. & Tsuji, M. (1997). Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J Immunol 158, 1268-1274.
31. Shiver, J. W. & Emini, E. A. (2004). Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu Rev Med 55, 355-372.
32. Shiver, J. W., Fu, T. M., Chen, L., Casimiro, D. R., Davies, M. E., Evans, R. K., Zhang, Z. Q., Simon, A. J., Trigona, W. L. & other authors (2002). Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331-335.
33. Slifka, M. K., Shen, H., Matloubian, M., Jensen, E. R., Miller, J. F. & Ahmed, R. (1996). Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. J Virol 70, 2902-2910.
34. Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z. Y., Roederer, M., Koup, R. A., Jahrling, P. B. & Nabel, G. J. (2003). Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424, 681-684.
35. Sun, J. C. & Bevan, M. J. (2003). Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300, 339-342.
36. Thomsen, A. R., Volkert, M. & Marker, O. (1979). The timing of the immune response in relation to virus growth determines the outcome of the LCM infection. Acta Pathol Microbiol Scand (C) 87C, 47-54.
37. Thomsen, A. R., Johansen, J., Marker, O. & Christensen, J. P. (1996). Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J Immunol 157, 3074-3080.
38. 2-microglobulin constructs. J Immunol 160, 1598-1605.
39. 2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. J Immunol 162, 6024-6028.
40. Vanniasinkam, T. & Ertl, H. C. (2005). Adenoviral gene delivery for HIV-1 vaccination. Curr Gene Ther 5, 203-212.
41. Wherry, E. J., Blattman, J. N. & Ahmed, R. (2005). Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J Virol 79, 8960-8968.
42. Wodarz, D., May, R. M. & Nowak, M. A. (2000). The role of antigen-independent persistence of memory cytotoxic T lymphocytes. Int Immunol 12, 467-477.
43. Wu, Q., Moyana, T. & Xiang, J. (2001). Cancer gene therapy by adenovirus-mediated gene transfer. Curr Gene Ther 1, 101-122.
44. Wu, Q., Xia, D., Carlsen, S. & Xiang, J. (2005). Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancer. Curr Gene Ther 5, 237-247.
45. Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D. & Ahmed, R. (1998). Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188, 2205-2213.
46. Zarei, S., Abraham, S., Arrighi, J. F., Haller, O., Calzascia, T., Walker, P. R., Kundig, T. M., Hauser, C. & Piguet, V. (2004). Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo. J Virol 78, 7843-7845.
47. Zinkernagel, R. M. & Hengartner, H. (2004). On immunity against infections and vaccines: credo 2004. Scand J Immunol 60, 9-13.